Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Strategic Master's Award - Bioinformatics, Comput. Biology/Health Data Sci.

McMaster University

$27,000.00

Optimizing Disease Definitions Through Maximal Heritability and Genome-wide Canonical Analysis

FY 2025-26

Summary
The project investigates whether genetic and biological information can help develop clearer, more accurate disease definitions. Today, diagnostic criteria in healthcare practice are often based on consensus among clinical professionals rather than on more objective biological data. Meanwhile, many large databases track health records and disease diagnoses based on codes designed primarily for paperwork and billing. These labels often miss early or mild signs of disease, vary between hospitals, and do not reflect true biological differences between people. Therefore, current disease categories may not show who is truly at risk. This limits genetic research but also makes early detection and accurate diagnosis more difficult, posing challenges to clinical care. To address this gap, the study aimed to establish disease definitions based on biology rather than regulatory rules. More biology-based definitions could improve how we predict health risks and guide more targeted prevention strategies, especially for people with complex or long-term health needs. This approach could also help clinicians identify early-stage or atypical cases that don't neatly fit traditional diagnostic labels. By combining genetic and medical data, our research aims to produce disease definitions that are more reliable, more consistent across healthcare settings, and better at identifying early changes in health. In the long term, clearer disease definitions could support earlier diagnosis, help clinicians make more confident decisions, and allow medical teams to tailor care to an individual's underlying biology. These improvements can enhance prevention, treatment and overall understanding of many common diseases, contributing to more precise and effective health care.
Program
CIHR Strategic Master's Award - Bioinformatics, Comput. Biology/Health Data Sci.
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
562730
Name
Zhou Can
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Master's Award: Strategic Master's Award
Projecttitle
Optimizing Disease Definitions Through Maximal Heritability and Genome-wide Canonical Analysis
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
CIHR Strategic Master's Award - Bioinformatics, Comput. Biology/Health Data Sci.
Keyworddelim
Biological Trait-Based Outcome; Disease And Trait Definition Optimization; Genetic Epidemiology; Maximal Heritability; Precision Medicine
Abstract
The project investigates whether genetic and biological information can help develop clearer, more accurate disease definitions. Today, diagnostic criteria in healthcare practice are often based on consensus among clinical professionals rather than on more objective biological data. Meanwhile, many large databases track health records and disease diagnoses based on codes designed primarily for paperwork and billing. These labels often miss early or mild signs of disease, vary between hospitals, and do not reflect true biological differences between people. Therefore, current disease categories may not show who is truly at risk. This limits genetic research but also makes early detection and accurate diagnosis more difficult, posing challenges to clinical care. To address this gap, the study aimed to establish disease definitions based on biology rather than regulatory rules. More biology-based definitions could improve how we predict health risks and guide more targeted prevention strategies, especially for people with complex or long-term health needs. This approach could also help clinicians identify early-stage or atypical cases that don't neatly fit traditional diagnostic labels. By combining genetic and medical data, our research aims to produce disease definitions that are more reliable, more consistent across healthcare settings, and better at identifying early changes in health. In the long term, clearer disease definitions could support earlier diagnosis, help clinicians make more confident decisions, and allow medical teams to tailor care to an individual's underlying biology. These improvements can enhance prevention, treatment and overall understanding of many common diseases, contributing to more precise and effective health care.
Competitiondate
202601
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhou, Can
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~